Like a certain late lamented parrot, CardioExchange is no more. It has ceased to be.
The website was started by the New England Journal of Medicine and the Massachusetts Medical Society more than 5 years ago in the wake of the explosive and ubiquitous growth of social media. But the rise of social media also provoked tremendous uncertainty and even anxiety over its role in healthcare and medicine. In response to this major transformation of the media landscape, MMS and NEJM launched CardioExchange as an experiment in social media for cardiologists and other healthcare professionals interested in cardiovascular medicine.
Click here to read the full post on Forbes.
CardioBrief is four years old this month. It’s time for change.
Starting now, the news and commentary that in the past appeared here on CardioBrief.Org will appear on my section of the Forbes website. I will continue to cover the major cardiology-related news for an audience of healthcare professionals. There will be no major changes in what I write, though I will try to keep in mind that the business-oriented readers of Forbes might appreciate some additional background and explanation.
This site, CardioBrief.Org, will not go away. It will become something of a micro-blog, containing more but shorter items than in the past. Most of these posts will consist of a very brief summary or quote from source materials, with an accompanying link or links. This will include links to my own stories on Forbes. I’m not sure yet how, precisely, this will work out. Over the next few weeks and months I will experiment with different styles and formats for these CardioBrief posts.
I will also link to new content that appears on CardioExchange, where I have worked for the past three years as a consulting editor and news writer. CardioExchange is published by the New England Journal of Medicine and edited by the estimable, ubiquitous, and provocative Harlan Krumholz. I encourage all my readers who are healthcare professionals to join the site and take part in the thoughtful discussions that occur there. I am extremely grateful that CardioExchange will continue to allow me to reuse the news I write for them on Forbes.
Please don’t hesitate to let me know your thoughts about these changes, either in the comments section or via email.